Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3298

Actual shortage: 230 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 9 (0%)
Resolved: 3056 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

28 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-02-06 249766
APO-SUCRALFATE - TAB 1G 1G TABLET Actual shortage 2025-02-06 2025-02-06 249763
APO-CLARITHROMYCIN 500MG TABLET Actual shortage 2025-02-06 2025-02-06 249760
APO-DORZO-TIMOP 5MG 20MG SOLUTION SOLUTION Actual shortage 2025-02-06 2025-02-06 249755
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2025-02-06 2025-02-06 249752
APO-CLOPIDOGREL 75MG TABLET Actual shortage 2025-02-06 2025-02-06 249749
APO-MELOXICAM 1.5G SUSPENSION Actual shortage 2025-02-06 2025-02-06 249746
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Actual shortage 2025-01-30 2025-01-30 249096
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-01-30 2025-01-30 249092
APO-RISPERIDONE 0.50MG TABLET Actual shortage 2025-01-30 2025-01-30 249089
APO-METRONIDAZOLE TABLETS 250MG TABLET Actual shortage 2025-01-30 2025-01-30 249080
APO-CANDESARTAN TABLETS 8MG TABLET Actual shortage 2025-01-30 2025-01-30 249077
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-01-30 2025-01-30 249074
APO-APREMILAST 30MG TABLET Resolved 2025-01-24 2025-01-31 248558
APO-RIVASTIGMINE 4.5MG CAPSULE Actual shortage 2025-01-23 2025-02-06 248492
APO-NAPROXEN 500MG TABLET Actual shortage 2025-01-23 2025-01-23 248489
APO-BRIVARACETAM 75MG TABLET Actual shortage 2025-01-23 2025-01-23 248486
APO-METRONIDAZOLE 500MG CAPSULE Actual shortage 2025-01-23 2025-01-23 248483
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-01-16 2025-01-16 247901
APO-ARIPIPRAZOLE 15MG TABLET Resolved 2025-01-16 2025-01-31 247894

Showing 1 to 20 of 3298

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMITRIPTYLINE 75MG TABLET To be discontinued 2025-01-10 2025-01-10 247472
APO-AMITRIPTYLINE 50MG TABLET To be discontinued 2025-01-10 2025-01-27 247469
APO-AMITRIPTYLINE 25MG TABLET Discontinued 2025-01-10 2025-01-11 247466
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2025-01-10 2025-01-11 247462
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-08-06 217493
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-BICALUTAMIDE 50MG TABLET Discontinued 2022-03-25 2022-05-13 157376
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-AMOXI SUGAR FREE 250MG POWDER FOR SUSPENSION Discontinued 2020-06-22 2020-06-22 118526

Showing 1 to 20 of 359